PET biomarkers and probes for treatment response assessment in glioblastoma: a work in progress

ConclusionWhereas it appears that the use of old and new PET radiopharmaceuticals can advance the non-invasive assessment of treatment response in GBM, the optimal match of biomarker –probe pairs although highly needed is still being sought in particular with the active development of new highly specific treatments characterized by novel antitumoral targeting strategies.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research